The Business Research Company published its Oncology Drugs Global Market Report 2020 which provides strategists, marketers and senior management with the critical information they need to assess the global Oncology Drugs market. The report provides in-depth analysis of the impact of COVID-19 on the market, along with revised market numbers due to the effects of the coronavirus.

The report covers the Oncology Drugs market’s segments-

1) By Type, Lung Cancer, Pancreatic Cancer, Breast Cancer, Prostate Cancer, Ovarian Cancer, Colorectal Cancer, Gastric Cancer, Kidney Cancer, Brain Tumor, Thyroid Cancer, Skin Cancer, Bladder Cancer, Cervical Cancer, Blood Cancer, Others (Kaposi Sarcoma, AIDS-Related Lymphoma, Anal Cancer, Bone Cancer, Retinoblastoma, Testicular Cancer, Hepatocellular (Liver) Cancer, Mouth Cancer, Neuroblastoma)

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others

3) By Route Of Administration: Oral, Parenteral, Others

4) By Drug Classification: Branded Drugs, Generic Drugs

5) By Mode Of Purchase: Prescription-Based Drugs, Over-The-Counter Drugs.

View Complete Report:

Oncology Drugs Global Market Report 2020 is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies. The chapter on the impact of COVID-19 gives valuable insights on supply chain disruptions, logistical challenges, and other economic implications of the virus on the market. The chapter also covers markets which have been positively affected by the pandemic.

The global oncology drugs market is expected to decline from $84.4 billion in 2019 to $75.5 billion in 2020 at a compound annual growth rate (CAGR) of -10.6%. The decline is mainly due to the COVID-19 outbreak and the measures to contain it. Hospitals across the world have postponed the chemo treatments for cancer patients due to covid positive cases in the hospitals. The sessions are delayed or postponed to prevent patients and staff from unnecessary exposure. The cancer treatment can lower the patient’s ability to fight infection. COVID-19 pandemic is affecting industries across the globe including the pharmaceutical sector. The disruptions due to extended factory closures in various countries, shortage of APIs and other chemicals, rise in prices of key ingredients, and slowed production are the key factors for this decline. The market is then expected to recover and grow at a CAGR of 8% from 2021 and reach $113.7 billion in 2023.

Companies are increasingly using cancer biomarkers in the drug development process. Cancer biomarkers are molecules secreted by a tumor or a specific response of the body to the presence of cancer. Identifying and targeting these can enhance cancer detection and facilitate high-speed noninvasive diagnosis using genomics and proteomics tools. It can also help predict the drug efficacy faster than conventional clinical endpoints, the point at which an undesired or abnormal effect of the drug is observed indicating withdrawal from therapy. Companies in this market are investing in the development of biomarkers for use in various activities such as tracking drug activity, the pharmacodynamics of drugs and to study diseases and treatment pathways.

Few Points From Table Of Content:

  1. Executive Summary
  2. Report Structure
  3. Oncology Drugs Market Characteristics
  4. Oncology Drugs Market Product Analysis
  5. Oncology Drugs Market Supply Chain


  1. Key Mergers And Acquisitions In The Oncology Drugs Market
  2. Market Background: Pharmaceutical Drugs Market
  3. Recommendations
  4. Appendix
  5. Copyright And Disclaimer

Request A Sample Report At:


Few Points From List Of Tables

Table 1: Historic Market Growth, Value ($ Billion)
Table 2: Forecast Market Growth, Value ($ Billion)
Table 3: Global Oncology Drugs Market, 2019, By Region, Value ($ Billion)
Table 4: Global Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Region
Table 5: Global Oncology Drugs Market, Growth And Market Share Comparison, By Region
Table 121: Global Pharmaceutical Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Region
Table 122: Global Pharmaceutical Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Segmentation By Type, Value ($ Billion)
Table 123: Global Oncology Drugs Market In 2023- Growth Countries
Table 124: Global Oncology Drugs Market In 2023- Growth Segments
Table 125: Global Oncology Drugs Market In 2023- Growth Strategies

About The Business Research Company:

Business Research Company is a Business Intelligence Company which excels in company, market and consumer research. It has offices in the UK, the US and India and a network of trained researchers in 52 countries globally.


Contact Information:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 8897263534

Americas: +1 315 623 0293

Email: [email protected]

Follow us on LinkedIn: